Table 4.
Risk factors associated with pregnant female patients with critical HFRS.
| Variables | Univariable logistic regression | |
|---|---|---|
| OR (95% CI) | p-value | |
| Age | 1.095 (0.919, 1.305) | 0.311 |
| Mid trimester of pregnancy | 0.200 (0.026, 1.526) | 0.121 |
| Late trimester of pregnancy | 0.833 (0.129, 5.396) | 0.848 |
| Late trimester of pregnancy vs. First and Mid trimester of pregnancy | 2.286 (0.475, 11.003) | 0.303 |
| Tmax at febrile phase | 2.327 (0.801, 6.760) | 0.120 |
| Duration of the febrile phase | 1.018 (0.689, 1.504) | 0.930 |
| SBP | 0.959 (0.889, 1.034) | 0.277 |
| DBP | 0.949 (0.877, 1.026) | 0.185 |
| Incidence of overlapping phase at admission | 9.625 (0.980, 94.540) | 0.052 |
| WBCmax at febrile phase | 1.139 (1.004, 1.291) | 0.043 |
| WBC ≥ 15 × 109/L | 22.000 (2.18, 221.974) | 0.009 |
| Nmax at febrile phase | 1.147 (0.984, 1.338) | 0.079 |
| PLTmin at febrile phase | 0.996 (0.971, 1.021) | 0.733 |
| HGB level at admission | 1.012 (0.983, 1.041) | 0.437 |
| ALB level at admission | 0.830 (0.679, 1.016) | 0.071 |
| Urine protein ≥ 3+ at admission | 2.800 (0.582, 13.478) | 0.199 |
HFRS, Hemorrhagic fever with renal syndrome; T, temperature; SBP, systolic blood pressure; DPB, diastolic blood pressure; WBC, white blood cell; N, neutrophile; PLT, platelet; HGB, hemoglobin; ALB, albumin.